Effect of an eccentric severe stenosis on fibrin(ogen) deposition on severely damaged vessel wall in arterial thrombosis. Relative contribution of fibrin(ogen) and platelets. 1994

A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
Cardiovascular Biology Research Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston.

BACKGROUND Coronary thrombosis is a dynamic process dependent on the pathological substrate, the local shear forces, and blood factors. RESULTS We investigated the effect of a severe (80%) eccentric stenosis on fibrin(ogen) interaction with a deeply damaged vessel wall, its relation to platelet deposition in thrombus formation, and the influence of time on thrombus growth. Porcine 125I-fibrinogen and autologous 111In-platelets were injected into pigs instrumented for extracorporeal circulation and treated with low-dose heparin (aPTT ratio < 1.5) that has been previously shown and herein confirmed not to affect platelet and/or fibrin(ogen) attachment. Tunica media, as a model of severely injured vessel wall, was mounted in a tubular perfusion chamber containing an eccentric axisymmetric sinusoidal stenosis obstructing the lumen and exposed for 1, 5, and 10 minutes to perfusing blood. A shear rate of 424 s-1 at the laminar, parallel parabolic local flow perfused segments one to two orders of magnitude greater at the apex of the stenosis. Fibrin(ogen) deposition, its axial distribution with respect to the apex, and its relation to platelet deposition were determined by an ex vivo analysis of the test substrates. Fibrin(ogen) and platelet deposition were both significantly higher at the apex of the stenosis than at either the prestenotic or poststenotic area at all the studied perfusion times (P < .02). However, fibrin(ogen) deposition demonstrated a significantly smaller degree of increase from the prestenotic area to the apex as well as a smaller degree of decrease from the latter to the poststenotic region, compared with platelet deposition (P < .05). Although both fibrin(ogen) and platelet deposition increased over time, the ratio of fibrin(ogen) to platelets showed a progressive decrease that became significant from 5 to 10 minutes (P < .03) at either low or high shear rate. The rate of platelet deposition was relatively constant; however, fibrin(ogen) deposition progressively decreased, especially at the apex. CONCLUSIONS On severely damaged vessel wall, fibrin(ogen) and platelet deposition is maximal at the apex of the stenosis where shear rate is extremely high and parallel streamlines are deformed. Nevertheless, fibrin(ogen) deposition is significantly less dependent on high shear rate than is platelet deposition, and the pattern is not influenced by time. Finally, fibrin(ogen) deposition appears to be predominant in the thrombus layers adjacent to a severely damaged vessel wall regardless of the local shear stress levels and flow conditions.

UI MeSH Term Description Entries
D008955 Models, Cardiovascular Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment. Cardiovascular Model,Cardiovascular Models,Model, Cardiovascular
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D003251 Constriction, Pathologic The condition of an anatomical structure's being constricted beyond normal dimensions. Stenosis,Stricture,Constriction, Pathological,Pathologic Constriction,Constrictions, Pathologic,Pathologic Constrictions,Pathological Constriction,Stenoses,Strictures
D003328 Coronary Thrombosis Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION. Thrombosis, Coronary,Coronary Thromboses,Thromboses, Coronary
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
August 1994, Thrombosis research,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1998, Haemostasis,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
May 1988, Thrombosis research,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1990, Arteriosclerosis (Dallas, Tex.),
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1976, Journal of the Royal College of Physicians of London,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1997, Blood,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1984, Advances in experimental medicine and biology,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
January 1979, Thrombosis research,
A Mailhac, and J J Badimon, and J T Fallon, and A Fernández-Ortiz, and B Meyer, and J H Chesebro, and V Fuster, and L Badimon
April 1994, Thrombosis and haemostasis,
Copied contents to your clipboard!